The arc of biotechnology is one of breakthroughs and struggles, writes Tim Hunt, CEO of the Alliance for Regenerative ...

despite acknowledging Xencor's pipeline progress. The divergence in analyst views underscores the speculative nature of biotechnology investments and the importance of upcoming clinical data in ...

The European Commission is concerned that diverging policies in member states could derail the European Union's Strategy for Life Sciences and Biotechnology. The concern is expressed in the Commission ...

PASADENA, Calif, March 27, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings ... “Continued progress has been made in collaborative clinical studies with two global pharmaceutical companies ...

Supreme Court hearings on GM crops progress, DBT supports GM mustard, BioE3 policy focus, bio-agriculture growth in India.

ONP-002 Advances Toward Phase IIa Concussion Trial with Strengthened Financial Foundation and Industry MomentumSARASOTA, Fla.

Heltzen expressed excitement for the event, emphasizing the company's progress in advancing sustainable biotechnology through their innovative AI-engineered enzymes, known as exozymes, which aim ...

(RTTNews) - LIXTE Biotechnology Holdings, Inc. (LIXT), on Thursday, announced the latest progress with its proprietary compound, LB-100, for the treatment of ovarian and colorectal cancer.

“Continued progress has been made in collaborative ... and make them more vulnerable for immunotherapy. About LIXTE Biotechnology Holdings, Inc. This announcement contains certain forward ...

PASADENA, Calif, March 27, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. ("LIXTE” or the "Company”) (Nasdaq: ...